# Niagen Bioscience, Inc.: Form SC 13D/A, filed Aug 21, 2024

- Company: [Niagen Bioscience, Inc.](/companies/nage.md) (CIK 1386570)
- Form: SC 13D/A
- Filed: 2024-08-21
- Accepted by EDGAR: Aug 21, 2024, 06:05 ET
- Period: not reported
- Accession: 0001193125-24-204002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1386570/000119312524204002/d875211dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1386570/000119312524204002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1386570/000119312524204002/d875211dsc13da.htm

Filed Aug 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-204002. Last ingested by Listed: Nov 4, 2026, 16:21 ET. No prices; not investment advice.